Pangaea Biotech - Home

background

header

Our mission is to generate a new framework of THERAPEUTIC ONCOLOGY based on personalized models, and incorporate this strategy into standard medical practice.

header

Our mission is to generate a new framework of THERAPEUTIC ONCOLOGY based on personalized models, and incorporate this strategy into standard medical practice.

header

Our mission is to generate a new framework of THERAPEUTIC ONCOLOGY based on personalized models, and incorporate this strategy into standard medical practice.

NEWS

Dr Miquel Taron, Co-Founder & CLO, to speak at 4th World Companion Diagnostics Summit.
Read more...

LAB TOUR

We were the first pharmacogenetic laboratory in Spain to receive accreditation.

Read more...

PUBLICATIONS

Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer.
N Engl J Med 2009
Read more...

Personalized Medicine

The notion of personalized medicine in anti-cancer intervention.

Read more: Personalized Medicine

Biomarker Discovery

We propose feasible and reproducible predictive signatures

Read more: Biomarker Discovery

Technology

We discover and develop predictive and prognostic markers of sensitivity/resistance to anticancer agents.

Read more: Technology

Business Development

Pangaea Biotech boasts a successful track record of strategic alliances with global pharma companies.

Read more: Business Development

Menu